Literature DB >> 9242214

Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system.

M E Burnett1, E C White, S Sih, M S von Haken, P H Cogen.   

Abstract

The current World Health Organization (WHO) classification groups together both infratentorial neoplasms (medulloblastomas) and their supratentorial counterparts as primitive neuroectodermal tumors (PNETs), implying a common origin. Previous analyses of medulloblastoma have shown loss of chromosome arm 17p as the most frequent genetic abnormality: the molecular genetic constitution of supratentorial PNETS has not been systematically studied. We therefore examined 8 hemispheric PNETs and 35 medulloblastomas with 17p restriction fragment length polymorphism (RFLP) and microsatellite markers. We also examined the TP53 tumor suppressor gene by a combined polymerase chain reaction-denaturing gradient gel (PCR-DGGE) technique. Our results showed that all of the 17p markers tested were preserved in all of the supratentorial PNET specimens. In contrast, loss of distal chromosome arm 17p was detected in 37% of the medulloblastomas. Analysis of the TP53 gene showed 2 mutations in the medulloblastomas and no mutations in the supratentorial tumors. These results show that the most common molecular genetic abnormality in infratentorial PNETS is absent in their supratentorial counterparts and suggests that alternative pathways and genetic events may be involved in their etiology.

Entities:  

Mesh:

Year:  1997        PMID: 9242214     DOI: 10.1016/s0165-4608(96)00319-6

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  22 in total

Review 1.  Review: In vivo models for defining molecular subtypes of the primitive neuroectodermal tumor genome: current challenges and solutions.

Authors:  Jon D Larson; David A Largaespada
Journal:  In Vivo       Date:  2012 Jul-Aug       Impact factor: 2.155

2.  Childhood pineoblastoma: experiences from the prospective multicenter trials HIT-SKK87, HIT-SKK92 and HIT91.

Authors:  Bernward G Hinkes; Katja von Hoff; Frank Deinlein; Monika Warmuth-Metz; Niels Soerensen; Beate Timmermann; Uwe Mittler; Christian Urban; Udo Bode; Torsten Pietsch; Paul G Schlegel; Rolf D Kortmann; Joachim Kuehl; Stefan Rutkowski
Journal:  J Neurooncol       Date:  2006-08-29       Impact factor: 4.130

Review 3.  Pediatric surgical neuro-oncology: current best care practices and strategies.

Authors:  James T Rutka; John S Kuo
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

4.  HDM2 promotes WIP1-mediated medulloblastoma growth.

Authors:  Meghan C Buss; Tracy-Ann Read; Matthew J Schniederjan; Khanjan Gandhi; Robert C Castellino
Journal:  Neuro Oncol       Date:  2012-02-29       Impact factor: 12.300

5.  Diagnostic application of high resolution single nucleotide polymorphism array analysis for children with brain tumors.

Authors:  Jacquelyn J Roth; Mariarita Santi; Lucy B Rorke-Adams; Brian N Harding; Tracy M Busse; Laura S Tooke; Jaclyn A Biegel
Journal:  Cancer Genet       Date:  2014-03-15

6.  A unique occurrence of a cerebral atypical teratoid/rhabdoid tumor in an infant and a spinal canal primitive neuroectodermal tumor in her father.

Authors:  Ewa Izycka-Swieszewska; Maria Debiec-Rychter; Bartosz Wasag; Agnieszka Wozniak; Dariusz Gasecki; Katarzyna Plata-Nazar; Jacek Bartkowiak; Jerzy Lasota; Janusz Limon
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

Review 7.  The ubiquitin-proteasome system and chromosome 17 in cerebellar granule cells and medulloblastoma subgroups.

Authors:  Jerry Vriend; Hassan Marzban
Journal:  Cell Mol Life Sci       Date:  2016-09-03       Impact factor: 9.261

8.  Amplification and overexpression of KIT, PDGFRA, and VEGFR2 in medulloblastomas and primitive neuroectodermal tumors.

Authors:  Tea Blom; Annariikka Roselli; Valtteri Häyry; Olli Tynninen; Kirmo Wartiovaara; Miikka Korja; Kristiina Nordfors; Hannu Haapasalo; Nina N Nupponen
Journal:  J Neurooncol       Date:  2009-09-25       Impact factor: 4.130

Review 9.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

10.  A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET.

Authors:  Murali Chintagumpala; Tim Hassall; Shawna Palmer; David Ashley; Dana Wallace; Kimberly Kasow; Thomas E Merchant; Matthew J Krasin; Robert Dauser; Frederick Boop; Robert Krance; Shiao Woo; Robyn Cheuk; Ching Lau; Richard Gilbertson; Amar Gajjar
Journal:  Neuro Oncol       Date:  2008-09-16       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.